IDEAS home Printed from https://ideas.repec.org/a/gam/jijerp/v19y2022i5p3018-d764208.html
   My bibliography  Save this article

Antiviral Drugs in Influenza

Author

Listed:
  • Magdalena Świerczyńska

    (Centre for Preclinical Research and Technology CePT, Department of Experimental and Clinical Pharmacology, Medical University of Warsaw, Banacha 1B, 02-097 Warsaw, Poland)

  • Dagmara M. Mirowska-Guzel

    (Centre for Preclinical Research and Technology CePT, Department of Experimental and Clinical Pharmacology, Medical University of Warsaw, Banacha 1B, 02-097 Warsaw, Poland)

  • Edyta Pindelska

    (Department of Analytical Chemistry and Biomaterials, Faculty of Pharmacy, Medical University of Warsaw, Banacha 1B, 02-093 Warsaw, Poland)

Abstract

Flu is a serious health, medical, and economic problem, but no therapy is yet available that has satisfactory results and reduces the occurrence of these problems. Nearly 20 years after the registration of the previous therapy, baloxavir marboxil, a drug with a new mechanism of action, recently appeared on the market. This is a promising step in the fight against the influenza virus. This article presents the possibilities of using all available antiviral drugs specific for influenza A and B. We compare all currently recommended anti-influenza medications, considering their mechanisms of action, administration, indications, target groups, effectiveness, and safety profiles. We demonstrate that baloxavir marboxil presents a similar safety and efficacy profile to those of drugs already used in the treatment of influenza. Further research on combination therapy is highly recommended and may have promising results.

Suggested Citation

  • Magdalena Świerczyńska & Dagmara M. Mirowska-Guzel & Edyta Pindelska, 2022. "Antiviral Drugs in Influenza," IJERPH, MDPI, vol. 19(5), pages 1-30, March.
    • Handle: RePEc:gam:jijerp:v:19:y:2022:i:5:p:3018-:d:764208
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/1660-4601/19/5/3018/pdf
    Download Restriction: no
    File URL: https://www.mdpi.com/1660-4601/19/5/3018/
    Download Restriction: no
    ---><---

    References listed on IDEAS

    as
    1. Sierk D. Marbus & Valentijn A. Schweitzer & Geert H. Groeneveld & Jan J. Oosterheert & Peter M. Schneeberger & Wim Hoek & Jaap T. Dissel & Arianne B. Gageldonk-Lafeber & Marie-Josée Mangen, 2020. "Incidence and costs of hospitalized adult influenza patients in The Netherlands: a retrospective observational study," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 21(5), pages 775-785, July.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. E.V. Popov, 2021. "Drivers of the Economy in the Context of the Coronavirus Pandemic," Journal of Applied Economic Research, Graduate School of Economics and Management, Ural Federal University, vol. 20(1), pages 5-30.
    2. Robert Susło & Piotr Pobrotyn & Lidia Brydak & Łukasz Rypicz & Urszula Grata-Borkowska & Jarosław Drobnik, 2021. "Seasonal Influenza and Low Flu Vaccination Coverage as Important Factors Modifying the Costs and Availability of Hospital Services in Poland: A Retrospective Comparative Study," IJERPH, MDPI, vol. 18(10), pages 1-15, May.
    3. Mercè Soler-Font & Ignacio Aznar-Lou & Luca Basile & Núria Soldevila & Pere Godoy & Ana Martínez & Antoni Serrano-Blanco & Angela Domínguez & The Surveillance of Hospitalized Cases of Severe Influenza, 2022. "Costs and Factors Associated with Hospitalizations Due to Severe Influenza in Catalonia (2017–2020)," IJERPH, MDPI, vol. 19(22), pages 1-10, November.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:19:y:2022:i:5:p:3018-:d:764208. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.